Sijimedtec Obtains Approval for Patient-Specific Spinal Cage Manufacturing Product

Design Optimized for Anatomical Structure
Aiming to Reduce Production Time from Three Weeks to Three Days

Orthopedic implant research and manufacturing company CJ MedTech recently announced on the 21st that it has obtained medical device manufacturing approval from the Ministry of Food and Drug Safety for its 'Patient-Specific Interbody Fusion (PSIF)' cage.

Patient Specific Interbody Fusion (PSIF) cage by Sigimedtec. Provided by Sigimedtec

Interbody fusion is a treatment method that involves inserting an implant between the vertebrae (intervertebral space) to induce the bone tissue to fuse into one. It is used in surgeries for disc diseases or spinal deformities. This product is a customized cage (implant) designed to fit the patient's spinal structure to assist this fusion.

Based on the patient's X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) data, it is produced with a 3D printer tailored to the individual patient's anatomical structure. Unlike conventional standard cages, it is manufactured reflecting the patient's anatomical characteristics, allowing for more precise spinal alignment and enabling customized surgery suitable for each patient, according to the company.

CJ MedTech plans to collaborate with hospitals from the second half of the year to evaluate and verify the product's performance. Through this, they will verify the actual therapeutic effects and usability, and improve the product by incorporating feedback from medical professionals. Additionally, they are considering developing a system that can reduce the cage manufacturing period from about three weeks to approximately three days.

This content was produced with the assistance of AI translation services.